Kazuto Tajiri

5.4k total citations
93 papers, 2.2k citations indexed

About

Kazuto Tajiri is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Kazuto Tajiri has authored 93 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Hepatology, 42 papers in Epidemiology and 23 papers in Surgery. Recurrent topics in Kazuto Tajiri's work include Liver Disease Diagnosis and Treatment (30 papers), Hepatocellular Carcinoma Treatment and Prognosis (20 papers) and Hepatitis C virus research (19 papers). Kazuto Tajiri is often cited by papers focused on Liver Disease Diagnosis and Treatment (30 papers), Hepatocellular Carcinoma Treatment and Prognosis (20 papers) and Hepatitis C virus research (19 papers). Kazuto Tajiri collaborates with scholars based in Japan, China and United States. Kazuto Tajiri's co-authors include Yukihiro Shimizu, Toshiro Sugiyama, Atsushi Muraguchi, Hiroyuki Kishi, Tatsuhiko Ozawa, Koichi Tsuneyama, Aishun Jin, Masami Minemura, Tsutomu Obata and Shinichi Kadowaki and has published in prestigious journals such as Nature Medicine, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Kazuto Tajiri

86 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kazuto Tajiri Japan 24 862 829 445 345 284 93 2.2k
Akitaka Shibuya Japan 27 1.6k 1.8× 1.3k 1.6× 594 1.3× 346 1.0× 306 1.1× 122 3.1k
Zhijun Wang China 24 387 0.4× 296 0.4× 600 1.3× 353 1.0× 152 0.5× 113 1.9k
Eckart Schott Germany 32 1.7k 1.9× 1.6k 1.9× 708 1.6× 230 0.7× 798 2.8× 69 3.6k
Michio Kato Japan 22 973 1.1× 1.0k 1.2× 449 1.0× 196 0.6× 237 0.8× 104 1.9k
Chih‐Wen Lin Taiwan 22 415 0.5× 1.2k 1.5× 483 1.1× 232 0.7× 112 0.4× 73 2.0k
Jens Werner Germany 22 311 0.4× 599 0.7× 426 1.0× 929 2.7× 592 2.1× 97 2.2k
John Koskinas Greece 32 2.1k 2.5× 2.0k 2.4× 417 0.9× 314 0.9× 223 0.8× 140 3.5k
Peng Zhu China 25 554 0.6× 326 0.4× 440 1.0× 355 1.0× 240 0.8× 107 1.6k

Countries citing papers authored by Kazuto Tajiri

Since Specialization
Citations

This map shows the geographic impact of Kazuto Tajiri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kazuto Tajiri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kazuto Tajiri more than expected).

Fields of papers citing papers by Kazuto Tajiri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kazuto Tajiri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kazuto Tajiri. The network helps show where Kazuto Tajiri may publish in the future.

Co-authorship network of co-authors of Kazuto Tajiri

This figure shows the co-authorship network connecting the top 25 collaborators of Kazuto Tajiri. A scholar is included among the top collaborators of Kazuto Tajiri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kazuto Tajiri. Kazuto Tajiri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tajiri, Kazuto, et al.. (2024). A Case of Immune-Related Aseptic Meningitis during Atezolizumab plus Bevacizumab for Hepatocellular Carcinoma. Case Reports in Gastroenterology. 18(1). 8–13.
3.
Tajiri, Kazuto, Kazuhiko Okada, Hiroyuki Ito, et al.. (2023). Long term changes in thrombocytopenia and leucopenia after HCV eradication with direct-acting antivirals. BMC Gastroenterology. 23(1). 182–182.
4.
Tajiri, Kazuto, et al.. (2023). An Autopsy Case of Ruptured Hepatic Angiosarcoma Treated by Transcatheter Arterial Embolization. Case Reports in Gastroenterology. 17(1). 309–315.
5.
Tajiri, Kazuto, et al.. (2023). A ruptured sarcomatoid hepatocellular carcinoma treated with combined immunotherapy. Clinical Journal of Gastroenterology. 16(2). 244–249. 4 indexed citations
6.
Kobayashi, Eiji, Aishun Jin, Hiroshi Hamana, et al.. (2022). Rapid cloning of antigen-specific T-cell receptors by leveraging the cis activation of T cells. Nature Biomedical Engineering. 6(7). 806–818. 7 indexed citations
7.
Tajiri, Kazuto, Yoshiharu Tokimitsu, Kengo Kawai, et al.. (2022). Impact of Post-progression Survival on Outcomes of Lenvatinib Treatment for Unresectable Hepatocellular Carcinoma: A Systematic Review and Retrospective Cohort Study. Anticancer Research. 42(12). 6007–6018. 3 indexed citations
8.
Takahashi, Kosuke, Ichiro Yasuda, Yuka Hayashi, et al.. (2020). Diagnostic Fine-Needle Biopsy of Small Solid Pancreatic Lesions Using a Franseen Needle during Endoscopic Ultrasound Examination. Diagnostics. 11(1). 27–27. 14 indexed citations
9.
Suzuki, Naomi, Kazuto Tajiri, Shinichi Tanaka, et al.. (2020). Perforation of the Small Intestine after Introduction of Lenvatinib in a Patient with Advanced Hepatocellular Carcinoma. Case Reports in Gastroenterology. 14(1). 63–69. 11 indexed citations
10.
Hiraoka, Atsushi, Takashi Kumada, Kunihiko Tsuji, et al.. (2018). Validation of Modified ALBI Grade for More Detailed Assessment of Hepatic Function in Hepatocellular Carcinoma Patients: A Multicenter Analysis. Liver Cancer. 8(2). 121–129. 149 indexed citations
11.
Hiraoka, Atsushi, Takashi Kumada, Kazuya Kariyama, et al.. (2018). Therapeutic potential of lenvatinib for unresectable hepatocellular carcinoma in clinical practice: Multicenter analysis. Hepatology Research. 49(1). 111–117. 57 indexed citations
12.
Tajiri, Kazuto, Yoshiharu Tokimitsu, Yoshinari Atarashi, et al.. (2018). Survival Benefit of Tolvaptan for Refractory Ascites in Patients with Advanced Cirrhosis. Digestive Diseases. 36(4). 314–321. 9 indexed citations
13.
Tajiri, Kazuto, et al.. (2018). Gastric Metastasis of Hepatocellular Carcinoma Mimicking Early Gastric Cancer. Clinical Gastroenterology and Hepatology. 16(10). e99–e100. 3 indexed citations
14.
Tajiri, Kazuto & Yukihiro Shimizu. (2017). Recent advances in the management of pruritus in chronic liver diseases. World Journal of Gastroenterology. 23(19). 3418–3418. 37 indexed citations
15.
Hiraoka, Atsushi, Takashi Kumada, Masashi Hirooka, et al.. (2017). A better method for assessment of hepatic function in hepatocellular carcinoma patients treated with radiofrequency ablation: Usefulness of albumin–bilirubin grade. Hepatology Research. 48(3). E61–E67. 17 indexed citations
16.
Hiraoka, Atsushi, Takashi Kumada, Masatoshi Kudo, et al.. (2017). Hepatic Function during Repeated TACE Procedures and Prognosis after Introducing Sorafenib in Patients with Unresectable Hepatocellular Carcinoma: Multicenter Analysis. Digestive Diseases. 35(6). 602–610. 100 indexed citations
17.
Yotsuyanagi, Hiroshi, Yasuhito Tanaka, Akihiko Saitoh, et al.. (2012). Universal vaccination of hepatitis B virus vaccine. Kanzo. 53(2). 117–130. 2 indexed citations
18.
Ozawa, Tatsuhiko, Aishun Jin, Kazuto Tajiri, et al.. (2011). Characterization of a fully human monoclonal antibody against extracellular domain of matrix protein 2 of influenza A virus. Antiviral Research. 91(3). 283–287. 11 indexed citations
19.
Tanaka, Yasuhito, Hiroshi Yotsuyanagi, Koji Yano, et al.. (2009). Universal hepatitis B vaccination: pros and cons. Kanzo. 50(10). 598–604. 1 indexed citations
20.
Tajiri, Kazuto & Yukihiro Shimizu. (2008). Practical guidelines for diagnosis and early management of drug-induced liver injury. World Journal of Gastroenterology. 14(44). 6774–6774. 139 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026